Seres Therapeutics, Inc. (MCRB) NASDAQ

17.90

+0.46(+2.64%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap2.58B
Enterprise Value2.64B
P/E Ratio29.07
PEG Ratio-0.31
Price/Sales Ratio24.9
Price/Book Ratio3.59
Enterprise/Revenue30.86
Enterprise/EBITDA-2.4

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.85
Operating Margin-16.39

Management Effectiveness

Return On Assets0.04
Return On Equity0.15

Income Statement

Revenue0
Revenue/Share0.72
Gross Profit-3.53M
EBITDA-120.3M
Net Income136,000
Diluted EPS-18.86

Balance Sheet

Total Cash47.64M
Total Cash/Share5.44
Total Debt85.25M
Total Debt/Equity1.95
Current Ratio2.3
Book Value Per Share4.99

Price History

52-Week Change9.28
52-Week High29.98
52-Week Low6.53
Moving Average 50 Days18.2
Moving Average 200 Days14.05

Statistics

Average Volume225,806
Shares Outstanding8.78M
% Held by Institutions24.31

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateApril 22, 2025